Take a look at this release from Doru Roiban’s group where they outline GSK’s perspective on the current status of biocatalysis for pharmaceutical manufacturing.

#biocatalysis #Enzymes

“This need for speed applies both to initial identification of a potential industrialisable biocatalyst and its subsequent development and scale up.”

Our next generation enzyme discovery can support you to achieve a faster time-to-market!

Innophore GmbH